[
  {
    "ts": null,
    "headline": "Crispr Therapeutics: Patience And Opportunity Through Volatility",
    "summary": "CRISPR Therapeutics analysis: long-term upside despite volatility. Track Casgevy ramp, pipeline milestones & cash runway.",
    "url": "https://finnhub.io/api/news?id=89047c96a595659788a2b7bb70ab59e059bef0b6f8f6f62953a86e33fab86f5b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768390208,
      "headline": "Crispr Therapeutics: Patience And Opportunity Through Volatility",
      "id": 138112347,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2180173390/image_2180173390.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "CRISPR Therapeutics analysis: long-term upside despite volatility. Track Casgevy ramp, pipeline milestones & cash runway.",
      "url": "https://finnhub.io/api/news?id=89047c96a595659788a2b7bb70ab59e059bef0b6f8f6f62953a86e33fab86f5b"
    }
  }
]